Scientists have used a form of artificial intelligence to create a map that compares types of cellular receptors, the chemical “antennas” on the surface of immune system T-cells. Their experiments with lab-grown mouse and human T-cells suggest that people with cancer who have a greater variety of such receptors may respond better to immunotherapy drugs and vaccines.